Literature DB >> 21085561

Venlafaxine for depression and glossovulvodynia: a case report.

Alberto Miranda Sivelo1, Ma Henar Nuñez Rodríguez.   

Abstract

Entities:  

Year:  2010        PMID： 21085561      PMCID： PMC2983451          DOI： 10.4088/PCC.09l00902blu

Source DB:  PubMed          Journal:  Prim Care Companion J Clin Psychiatry        ISSN： 1523-5998


× No keyword cloud information.
  7 in total

1.  An inventory for measuring depression.

Authors:  A T BECK; C H WARD; M MENDELSON; J MOCK; J ERBAUGH
Journal:  Arch Gen Psychiatry       Date:  1961-06

Review 2.  Depression and skin disease.

Authors:  Richard G Fried; Madhulika A Gupta; Aditya K Gupta
Journal:  Dermatol Clin       Date:  2005-10       Impact factor: 3.478

Review 3.  SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants.

Authors:  Stephen M Stahl; Meghan M Grady; Chantal Moret; Mike Briley
Journal:  CNS Spectr       Date:  2005-09       Impact factor: 3.790

4.  Burning mouth syndrome and vulvodynia coexisting in the same patient: a case report.

Authors:  Pallavi Gaitonde; J Rostron; L Longman; E A Field
Journal:  Dent Update       Date:  2002-03

5.  Efficacy of venlafaxine for the long term treatment of chronic pain with associated major depressive disorder.

Authors:  Ronald H Bradley; Robert L Barkin; John Jerome; Kevin DeYoung; Charles William Dodge
Journal:  Am J Ther       Date:  2003 Sep-Oct       Impact factor: 2.688

Review 6.  Antidepressant agents for the treatment of chronic pain and depression.

Authors:  Michael W Jann; Julian H Slade
Journal:  Pharmacotherapy       Date:  2007-11       Impact factor: 4.705

7.  Vulvostomatodynia.

Authors:  Massimo Petruzzi; Michele De Benedittis; Luca Pastore; Rosario Serpico
Journal:  Maturitas       Date:  2007-06-29       Impact factor: 4.342
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.